Abstract Details
|
Sarah Wahlster, MD
PRESENTER |
Dr. Wahlster has nothing to disclose. |
| Lindsay R. Chura, PhD (AARP) | No disclosure on file |
| Eelco F. Wijdicks, MD, FÂ鶹´«Ã½Ó³» (Mayo Clinic W8) | Dr. Wijdicks has received publishing royalties from a publication relating to health care. |
| Pratik V. Patel, MD | No disclosure on file |
| David M. Greer, MD, FÂ鶹´«Ã½Ó³» (Boston University School of Medicine) | Dr. Greer has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Thieme, Inc. Dr. Greer has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for multiple. Dr. Greer has received publishing royalties from a publication relating to health care. Dr. Greer has received publishing royalties from a publication relating to health care. Dr. Greer has received publishing royalties from a publication relating to health care. Dr. Greer has a non-compensated relationship as a Treasurer-Elect with American Neurological Association that is relevant to Â鶹´«Ã½Ó³» interests or activities. Dr. Greer has a non-compensated relationship as a President with Neurocritical Care Society that is relevant to Â鶹´«Ã½Ó³» interests or activities. |
| Claude Hemphill III, MD, FÂ鶹´«Ã½Ó³» (Zuckerberg San Francisco General Hospital) | Dr. Hemphill has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Zoll. Dr. Hemphill has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Aurenar. Dr. Hemphill has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for various legal firms. The institution of Dr. Hemphill has received research support from NIH/NINDS. |
| Farrah J. Mateen, MD, PhD, FÂ鶹´«Ã½Ó³» (Northwestern University Department of Neurology) | Dr. Mateen has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Mateen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Mateen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Mateen has received research support from Genentech. The institution of Dr. Mateen has received research support from Amgen. The institution of Dr. Mateen has received research support from TG Therapeutics. Dr. Mateen has received intellectual property interests from a discovery or technology relating to health care. |